The Office of Personalized Genomics and Innovative Medicine (OPGIM) was established at Toronto’s Mount Sinai Hospital to enable and promote the implementation of a personalized health care approach to the diagnosis and treatment of hereditary diseases such cancer, cardiac disease and rheumatoid arthritis.
This will be achieved in collaboration with our Clinical Genomics centre, which has been providing genomics services, such as genotyping and DNA sequencing, to the local, national, and international biomedical community for over a decade.
Through ongoing partnerships with leading research and molecular diagnostic centres, the OPGIM will enable the implementation of exciting genetic/genomic discoveries into routine medical practice, and ultimately improve the speed and precision of disease diagnostics and the quality of patient care.
Our five major objectives include:
Our mission also aims to: